Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05848271 · ClinicalTrials.gov registry record
Natural History Study of Patients with HPDL Mutations
A clinical trial of Genetic Disease and Neonatal Encephalopathy, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT05848271: Recruiting study of Genetic Disease and Neonatal Encephalopathy, sponsored by University of California, San Diego.
NCT05848271 is a study of Genetic Disease and Neonatal Encephalopathy that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 50 participants, below the 2,560-participant average among 30 other Genetic Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05848271, a study of Genetic Disease and Neonatal Encephalopathy, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study uses medical records that allow retrospective data extraction of clinical manifestation to assess the natural history of HPDL mutations
Primary Outcome
Clinician-reported clinical and genetic confirmation of HPDL mutations
Conditions Studied
Interventions
- OTHER Patient Registry
- OTHER Dry blood spots sampling
Study Locations (1)
California
- Eun Hae Lee - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-05-18 |
| Est. Completion | 2027-12-31 |
What NCT05848271 shows while recruiting
NCT05848271 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 2,560-participant average among 30 other Genetic Disease trials with a reported enrollment target (98% lower).
The record links to 7 conditions, with Genetic Disease appearing as the primary indexed condition, and to 2 interventions - of which Patient Registry is the first listed.
NCT05848271 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05848271 about?
NCT05848271 is a clinical study titled "Natural History Study of Patients with HPDL Mutations". This study uses medical records that allow retrospective data extraction of clinical manifestation to assess the natural history of HPDL mutations
What is the current status of trial NCT05848271?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2023-05-18. Estimated completion is 2027-12-31.
What conditions does trial NCT05848271 study?
This clinical trial studies the following conditions: Genetic Disease, Neonatal Encephalopathy, Hereditary Spastic Paraplegia, White Matter Disease, Mitochondrial Encephalomyopathies.
What interventions are being tested in trial NCT05848271?
The interventions under investigation include: Patient Registry (OTHER), Dry blood spots sampling (OTHER).
Who is sponsoring clinical trial NCT05848271?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05848271 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05848271's enrollment target sits among peer trials
50 25th of 30 higher than 6 of 30 other Genetic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Genetic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
RECRUITING
-
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
RECRUITING
-
Follow-up With Preimplantation Genetic Testing Patients
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI